RAYBOW PHARMACEUTICAL
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

RAYBOW PHARMACEUTICAL Trademark

Serial Number: 79270024 • Registration: 6115538

RAYBOW PHARMACEUTICAL is a trademark filed by Zhejiang Raybow Pharmaceutical Co., Ltd. on July 16, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Zhejiang Raybow Pharmaceutical Co., Ltd.

18, Nanyang San Road,

Entity Type: 99

Trademark Details

Filing Date

July 16, 2019

Registration Date

August 4, 2020

Published for Opposition

May 19, 2020

Goods & Services

Distribution of products in the field of pharmaceuticals, namely, transportation and delivery of health care preparations in the form of pharmaceutical products, including finished products and semi-finished products for veterinary and cosmetic purposes

Medical, pharmaceutical and veterinary preparations and substances, namely, for the treatment of cancer, cardiovascular disorders, endocrinological disorders, neurological disorders, dermatological disorders, respiratory disorders; as well as health care preparations, namely, pharmaceutical preparations for the treatment of cancer, cardiovascular disorders, endocrinological disorders, neurological disorders, dermatological disorders, respiratory disorders; medicines for the treatment of diseases associated with the central nervous system; hypoglycemic drugs; medicines for the treatment of antiviral disorders; medicines for the treatment of tumors; cardiovascular treatment preparations; nonsteroidal anti-inflammatory drugs; anti-infectives; chemical preparations for veterinary or pharmaceutical purposes, namely for the treatment of cancer, cardiovascular disorders, endocrinological disorders, neurological disorders, dermatological disorders, respiratory disorders

Medical services, veterinary services; medical consultancy in the field of healthcare and dispensing of pharmaceutical preparations and pharmaceutical consultancy in the field of healthcare and dispensing of pharmaceutical preparations, the aforesaid services also provided via electronic networks, including the internet

Pharmaceutical research for the discovery of new drugs; scientific research, in particular in the medical, biomedical, chemical, genetic, pharmaceutical or veterinary fields; research and development of new pharmaceutical preparations for others; scientific research in the field of pharmacy

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 4, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 12, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 25, 2020 FICS
FINAL DISPOSITION PROCESSED
Nov 25, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 4, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 4, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 19, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 19, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 29, 2020 NONP
ASSIGNED TO LIE
Apr 13, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 6, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 4, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 3, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 3, 2020 TROA
REFUSAL PROCESSED BY IB
Dec 20, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 19, 2019 RFCS
REFUSAL PROCESSED BY MPU
Nov 19, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Oct 29, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 27, 2019 RFCR
NON-FINAL ACTION WRITTEN
Oct 26, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 25, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 24, 2019 REPR